Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.

(Reuters) -Indian pharmaceutical stocks shed 1.3% on Monday, even as the broader markets rose, after U.S. President Donald Trump said he would sign an executive order to cut prescription prices to the level paid by other high-income countries,

President Donald Trump on Monday revived a plan to tie prescription drug prices in the U.S. to what other nations pay for medicines. The executive order, which was first reported by POLITICO, still leaves many questions about how the administration will implement a so-called “most-favored nation” policy.